Post-approval studies (Phase 4)Study completedNCT00564941
What this trial is testing
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload
Who this might be right for
Myelodysplastic SyndromesBeta-Thalassemia
Novartis Pharmaceuticals 309